Giribaldi B
Centre for Psychedelic Research, Imperial College London. Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
ArticlePsilocybin
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.
ArticlePsilocybin
Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.
ArticlePsilocybin
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
PreprintPsilocybin
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial
ArticlePsilocybin
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
ArticlePsilocybin
Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.
ArticlePsilocybin
Psychedelics and sexual functioning: a mixed-methods study.
ArticlePsilocybin
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
ArticlePsilocybin
Body mass index (BMI) does not predict responses to psilocybin.
ArticlePsilocybin
A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.
ArticlePsilocybin
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
ArticlePsilocybin